While several studies are reported addressing the effect of PD-1 (PDCD1) inhibitors in gliomas and leukemia patients, to date only one study is reported in Clinicaltrials.gov investigating PD-1 inhibitors (namely nivolumab) in testis cancers [45]. Here, PDCD1 is linked to testicular cancer.